[Table/Fig-1]:
Details of the prticipants in the study. Values represented as mean +SD, *** represents p<0.001 when compared to PD3 group, ### represents p<0.001 when compared with PD2. LED: levodopa equivalent dosage [17].
| Parameters | PD3 | PD1 | PD2 | Controls | p value |
|---|---|---|---|---|---|
| Numbers of subject (n) | 12 | 12 | 12 | 12 | |
| HY Scale | 4 | 2 | 3 | -- | -- |
| Age (Years) | 54.6±75.36 | 54.00±3.28 | 55.25±3.96 | 54.50±4.46 | 0.916 |
| Duration of disease (years) | 13.33±2.50 | 7.50±1.98*** | 8.92±2.43*** | -- | <0.001 |
| UPDRS III motor score | 37.92±9.92 | 13.83±4.53***### | 25.42±4.74*** | -- | <0.001 |
| LED (mg/day) | 6888±194.81 | 409.08±158.60 | 991.78±257.35 | -- | -- |